MyAverix Finance
F · Healthcare
Mayne Pharma Group Limited (HG6)
Medical Distribution
Mayne Pharma Group Limited (HG6) is listed on F in the Healthcare sector. Industry: Medical Distribution. As of 2026-03-29, reported market cap is $107.35M, P/E ratio is 18.00, net margin is -20.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HG6
Mayne Pharma Group Limited (HG6) — FAQ
What is Mayne Pharma Group Limited's market cap?
Mayne Pharma Group Limited (HG6) has a reported market cap of $107.35M (data as of 2026-03-29).
What is HG6's P/E ratio?
The price-to-earnings (P/E) ratio for Mayne Pharma Group Limited (HG6) is 18.00 (data as of 2026-03-29).
Does Mayne Pharma Group Limited pay a dividend?
Dividend yield is not available in the current snapshot for Mayne Pharma Group Limited (HG6). Check the MyAverix Finance app for the latest dividend data.
What sector is Mayne Pharma Group Limited in?
Mayne Pharma Group Limited (HG6) is classified in the Healthcare sector (Medical Distribution industry).
What exchange is HG6 listed on?
HG6 is listed on F.
What is Mayne Pharma Group Limited's net margin?
Mayne Pharma Group Limited (HG6) reports a net margin of -20.4% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.